On changing lanes: A few words of caution
In this issue of Urology Times, we see interviews with several urologistswho have chosen to change paths in mid-career (see article, page 1). Havinggone through many of these issues myself, a few words of caution are inorder. Everyone goes through a period when they at least consider major changes,either because they have "been there, done that" and want somethingnew, or perhaps changes are forced upon them for personal or health reasons.Most of us have gone through the medical tract in life on somewhat of astraightaway. We go from high school to college, from college to medicalschool, from medical school to surgical and urology training, and embarkon our career. After several years of practice, looking at other fieldsand endeavors may be a natural progression for many of us.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
